Investment Q&A

Q: Could you give a list of 5i's portfolio holdings that you consider provides a significant (partial) substitute for direct U.S. or International investment choices, along with a rough percentage of how much of each holding you feel would qualify for our "non-Canadian" portion ? Many thanks.

Q: Do you know if there is already any shot activity on Shopify ? or any threat of such action.

Would Shopify be a suitable candidate for a "short attack"

Q: Good day

I will like your assistance on guiding my investment decision. I have read your report on Knight Therapeutics. After Knight has deployed its war chest($736,000,000), you are forecasting earnings per share of $0.59, plus the EPS for the last quarterly report of 0.06$. If earnings grow at 15% per year for the next 5 years, then in 2022, EPS will be :

2017 2018 2019 2020 2021 2022

$0.65 $0.75 $0.86 $0.99 $1.14 $1.31

I am assuming cash is deployed this year, the share count remains constant and investors in 2022 are willing to pay 15 times EPS. If this scenario holds, then in 2022, the share price should trade at around $20 (1.31 X 15). At current price ($10.60), this scenario would result in an annual rate of return for the next five years of 13.1%. Are you comfortable with my scenario or would you change some of my parameters ?

Gilles

Q: Hi, Could you please provide quarterly estimates for Rev, EBITDA and Adj EPS for KXS and SHOP. Thanks

Q: Is there any disadvantage to CRH's ability to make acquisitions caused by their negative share price momentum?

Q: Nice unexpected lift today from Agnico Eagle. Can you comment on their results?

Q: Do you think that the dust has settled with CRH yet ?

Would you say that it is still over-valued ? under-valued ?
or priced appropriately ?

Q: Looking for reassurance and Not a question per se, I am seeing many small amounts of shares being traded. No big blocks more than a few thousand which indicates that my fellow retail investors are leaving. Reminds me of when PHM was going to the dogs. I hope CRH isn't another medical shell game. Down 18 plus %.

Q: Not worrying about sector, which 5 stocks in the balanced portfolio have the most growth potential for the next twelve months from the price they currently trade at.

Q: Shopify reports next week, and I would assume there will be a large loss reported. Does that mean Monday we will see a large run on the stock and should we consider unloading to lighten exposure.
Thanks

Q: This is basically just an opinion but I think that last week the action with CRH was an example of what you really mean by volatility. The the 5 to 10% that happens some days for no good, obvious reason are to be expected in a growth portfolio and are just a healthy fluctuation in a share price. Such fluctuations actually strengthen the stock. Comment ?
Thanks for your support
Clarence

Q: In March and February your comments about this company were generally positive. Yet just recently you said that this company was the most likely candidate to be booted out of the balanced equity portfolio. Sounds like you views have changed in the past four weeks. Can you explain the apparent shift in your position please. Thx.

Q: Can you comment on Constellations Software's debt profile and cash position? From what I recall, it is a definite strength of the company. Is there any plausible short to medium term scenario where the company can destroy their strong financial position?

Q: Peter & Team, I think we do have a problem at CRH and it has to do with the minority interests (MI's) in that they are getting way too much of the business, possibly because of mix or maybe the joint ventures are the better operations.

$000
Earnings

                    Q1 '17               Q1 '16
Net Income        $3302                $ 3031
Att. to CRH          1542                  2956
Att. to MI's         1760                 75

CRH net income down almost 50%. How is it possible that the MI's can be getting more of the profit than CRH shareholders?

and

Cash flow

Cash flow provided 7991                 5524
Paid to MI's             4011                  627

Share to MI's             50%                  11%

Cash paid to the MI's is more than their share of the profits.

Year ago this was not an issue. Now it is!

What should we do here? The business as a whole looks fabulous, it is in a good space with strong and meaningful secular tailwinds, it has a huge 35% conversion of sales to cash flow, but something looks very wrong with the business model and the sharing of the cash and profits.

Kindly advise. Thank you. Keith

Q: Hi 5i, is it more upside for Pho? Wondering the share price usually dropped after release earning? Thank you.

Q: Comments please on Constellation's latest quarter.
Thank you

Q: Hi Peter and Team,
Is it CRH overvalued now? It seems that investors do not like the financial result and outlook. Your opinion please.
Thanks

Q: GUD. The stock seems stuck at 10.50$.

Would you advise simply resilience, and awaiting the outcome ?

Q: In your last answer on crh do you take into account the correction issued by the company regarding its first press release ?

Q: Which of these two, At current prices, would you buy today, assuming one has a balanced portfolio?

Thx
Karim